KALA BIO, INC. Cash and Cash Equivalents, Period Increase (Decrease)
KALA BIO, INC. (KALA) reported Cash and Cash Equivalents, Period Increase (Decrease) of $76.58 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2017-11-07
- KALA BIO, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was $95.70M.
- KALA BIO, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2016-09-30 was -$9.20M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month |
|---|---|---|---|
| 2017-09-30 | $95.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $76.58M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | -$19.12M 10-Q · filed 2017-08-31 | ||
| 2016-09-30 | -$9.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $46.12M 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $55.32M 10-Q · filed 2017-08-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |